title: [Lopinavir/ritonavir in human immunodeficiency virus-infected women].
abstract: There are clear sex-related biological differences between men and women. Diseases that affect the two sexes differently are studied separately. However, some diseases affect both men and women, but their incidence or outcome are clearly different. In human immunodeficiency virus infection, the potential differences in the effects of antiretroviral therapy are poorly characterized and few studies have been designed to elucidate these differences. Moreover, women are usually poorly represented in clinical trials of antiretroviral drugs.
authors.affiliation: Servicio de Medicina Interna/Unidad de Infecciosas, Hospital Clínico San Carlos, Madrid, España. Electronic address: mariajesus.tellez@salud.madrid.org.
authors.forename: María Jesús
authors.initials: MJ
authors.lastname: Téllez
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D049628:Body Size; D004338:Drug Combinations; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D061466:Lopinavir / Q000009:adverse effects / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D015337:Multicenter Studies as Topic; D018579:Patient Selection; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use*; D012727:Sex Characteristics
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; C558899:lopinavir-ritonavir drug combination; D061466:Lopinavir; D019438:Ritonavir
keywords: Antiretroviral therapy; HIV; Lopinavir/ritonavir; Mujeres; Tratamiento antirretroviral; VIH; Women